Apjohn ventures logo

Apjohn ventures

North America, Michigan, United States, Kalamazoo

Description

Apjohn Ventures Fund is a new venture capital firm based in Kalamazoo, Michigan established to invest primarily in early stage life

Investor Profile

Apjohn ventures has made 17 investments, with 0 in the past 12 months and 12% as lead.

Stage Focus

  • Series A (29%)
  • Series Unknown (29%)
  • Series B (18%)
  • Series C (12%)
  • Debt Financing (6%)
  • Series D (6%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Biotechnology
  • Life Science
  • Therapeutics
  • Oncology
  • Medical Device
  • Medical
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Apjohn ventures frequently co-invest with?

Orchard Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 2
SV Health Investors
North America, Massachusetts, United States, Boston
Co-Investments: 2
CS
North America, Kentucky, United States, Frankfort
Co-Investments: 2
Fort Washington Capital Partners Group
North America, Ohio, United States, Cincinnati
Co-Investments: 3
Prolog Ventures
North America, Missouri, United States, St Louis
Co-Investments: 2
Burrill & Company
North America, California, United States, San Francisco
Co-Investments: 2
Lurie Investment Fund
North America, Illinois, United States, Chicago
Co-Investments: 4
Grand Angels
North America, Michigan, United States, Holland
Co-Investments: 2
Capital Midwest Fund
North America, Wisconsin, United States, Milwaukee
Co-Investments: 2
North Coast Technology Investors
North America, Michigan, United States, Ann Arbor
Co-Investments: 3

Which angels does Apjohn ventures often collaborate with?

RF
North America, New Jersey, United States, New Providence
Shared Deals: 1
JT
North America, Florida, United States, West Palm Beach
Shared Deals: 1

What are some of recent deals done by Apjohn ventures?

Tetra Therapeutics

Grand Rapids, Michigan, United States

Tetra Therapeutics is a clinical stage biotechnology company developing a portfolio of therapeutic products.

BiotechnologyTherapeutics
Series ANov 29, 2016
Amount Raised: $5,000,000
Tetra Discovery

Grand Rapids, Michigan, United States

Tetra Discovery provides consulting services and research on drug discovery for diseases affecting the central nervous system.

BiotechnologyHealth CareLife Science
Series ANov 29, 2016
Amount Raised: $5,000,000
Sierra Oncology

San Mateo, California, United States

Sierra Oncology is a clinical-stage drug development company that advances targeted therapeutics for the treatment of cancer patients.

BiotechnologyHealth CareLife ScienceOncologyTherapeutics
Series DApr 21, 2014
Amount Raised: $59,500,000
CytoPherx

Ann Arbor, Michigan, United States

CytoPherx is a medical device company offering a proprietary selective cytopheresis sytem for inflammation-based diseases and conditions.

Health CareLife ScienceMedical Device
Series CJan 4, 2012
Amount Raised: $34,000,000
CytoPherx

Ann Arbor, Michigan, United States

CytoPherx is a medical device company offering a proprietary selective cytopheresis sytem for inflammation-based diseases and conditions.

Health CareLife ScienceMedical Device
Series BJun 17, 2010
Amount Raised: $11,700,000
Svelte Medical Systems

New Providence, New Jersey, United States

Svelte Medical Systems is a healthcare company engaged in the design and development of highly deliverable balloon expandable stents.

Health CareMedicalMedical Device
Debt FinancingNov 7, 2009
Amount Raised: $6,000,000
Intranasal Therapeutics

Montvale, New Jersey, United States

Ikano Therapeutics a specialty pharmaceutical company, focuses on developing nasal spray drug products.

BiotechnologyMedicalPharmaceuticalTherapeutics
Series BMar 30, 2009
Amount Raised: $18,000,000
Sierra Oncology

San Mateo, California, United States

Sierra Oncology is a clinical-stage drug development company that advances targeted therapeutics for the treatment of cancer patients.

BiotechnologyHealth CareLife ScienceOncologyTherapeutics
Series UnknownMay 30, 2008
Amount Raised: $12,500,000
CytoPherx

Ann Arbor, Michigan, United States

CytoPherx is a medical device company offering a proprietary selective cytopheresis sytem for inflammation-based diseases and conditions.

Health CareLife ScienceMedical Device
Series AOct 22, 2007
Amount Raised: $2,500,000
RenaMed Biologics

Westborough, Massachusetts, United States

RenaMed Biologics engages in the development of therapies for the treatment of diseases associated with compromised kidney function.

BiotechnologyHealth CareMedical
Series UnknownSep 7, 2006
Amount Raised: $40,000,000